Genomic Health (GHDX) Tops Q3 EPS by 7c
More News related to GHDX
- Genomic Health (GHDX) Reports Q4 Loss of $0.01, Beats by 5c; Guides FY10 Sales
- Genomic Health Announces Year-End 2009 Financial Results
- Trading Radar for 02/03: Cisco (CSCO), ON Semi (ONNN), Visa (V), Novellus (NVLS), Monster Worldwide (MWW) Report
- Genomic Health to Announce Fourth Quarter and Year-End 2009 Financial Results and Host Conference Call on Wednesday, February 3
- Piper Jaffray Upgrades Genomic Health (GHDX) to Overweight; Attractive Valuation
More News related to Earnings
- NetSol (NTWK) Reports Q2 Loss of $0.01, Misses by 2c; Reaffirms Guidance
- Rentech (RTK) Reports Q1 Loss of $0.07
- Textainer (TGH) Tops Q4 Earnings Views
- Sprint Nextel (S) Q4 Losses Narrow, But Miss Expectations
- Baldwin Technology (BLD) Posts Q2 Loss of $0.03, Misses by 4c
Genomic Health, Inc. (NASDAQ: GHDX) reports Q3 loss of $0.02, 7 cents better than the analyst estimate of ($0.09). Revenue for the quarter was $39.5 million, which compares to the estimate of $39.11 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
